Calendar Q32 Bio Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
26.59 ^USD	+4.27%		+10.24%	+142.96%

Apr. 11	Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target	MT
Apr. 03	Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer	CI

b7c1c1.RYFg8KiL1iNBA5hjspCYXRMcOU7Xwv8jEqK0zIYP-7o.CchWkuXpukA5RfwJ2emta3xxCAek9ZRva_2HtuFVl_99xQuY5sKGFQ5p-w~f2f8924ceafcf1314ae74983bb20a31e

No events available

2023-11-14 04:33 pm	Q3 2023 Earnings Release
2023-08-14 04:05 pm	Q2 2023 Earnings Release
2023-07-27 04:30 pm	Business Update Call
2023-06-13	Annual General Meeting
2023-05-24	World Orphan Drug Congress
2023-05-19 03:00 pm	American Society of Gene Cell Therapy Meeting - Abstract # 1312
2023-05-19 03:00 pm	American Society of Gene Cell Therapy Meeting - Abstract # 1497
2023-05-19 03:00 pm	American Society of Gene Cell Therapy Meeting - Abstract # 1355
2023-05-18 03:00 pm	American Society of Gene & Cell Therapy Meeting - Abstract # 989
2023-05-17 03:00 pm	American Society of Gene Cell Therapy Meeting - Abstract # 376
2023-05-17 03:00 pm	American Society of Gene Cell Therapy Meeting - Abstract # 386
2023-05-11 04:05 pm	Q1 2023 Earnings Release
2023-03-17 12:30 pm	ACMG Clinical Genetics Meeting
2023-03-16 12:30 pm	ACMG Clinical Genetics Meeting
2023-03-13	ACMG Clinical Genetics Meeting
2023-03-11 02:30 pm	Project Alive Hunter Syndrome Community Conference
2023-03-09 04:05 pm	Q4 2022 Earnings Release
2023-03-08 10:30 am	Cowen Health Care Conference - Panel
2022-11-15 04:10 pm	Stifel Healthcare Conference
2022-11-10 04:07 pm	Q3 2022 Earnings Release

Fiscal Period	December	2023	2024
Net sales Million USD	Released Forecast Spread	0,00	0,00
EBITDA	Released Forecast Spread	0,00	0,00
EBIT Million USD	Released Forecast Spread	0,00	-49,6
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-51,1
Net income Million USD	Released Forecast Spread	-53,7	-51,1
EPS USD	Released Forecast Spread	-7,41	-4,37
Announcement Date		27/03/24	-

Fiscal Period	December	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1
Net sales Million USD	Released Forecast Spread	0,00	0,00	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-11,9	-12,2	-12,5	-12,8	-13,7
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-14,9	-11,7	-12,1	-12,4	-13,7
Net income Million USD	Released Forecast Spread	-14,9	-11,7	-12,1	-12,4	-13,7
EPS USD	Released Forecast Spread	-1,42	-0,98	-1,01	-1,04	-0,80
Announcement Date		-	-	-	-	-

Today 06:30 am	SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25	REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-28	HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Today	JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today	BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
Today	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today	HITGEN INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm	VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-23	INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-23 07:30 am	KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-17	BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)